IMBI Brain Imaging Working Group 2019, ' Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 11, pp. 327-332 . https://doi.org/10.1016/j.dadm.2019.02.004 Perani, D, Iaccarino, L, Jacobs, A H, Lammertsma, A A, Nordberg, A, Windhorst, A D, Gerhard, A, Winkeler, A, Gee, A, Kuhnast, B, Halldin, C, Brooks, D, Rodriguez-Vieitez, E, Turkheimer, F E, López-Picón, F, Knudsen, G M, Vercouillie, J, Rinne, J O, Herholz, K, van Laere, K, Santiago-Ribeiro, M J, Herth, M M, Carroll, M A, Bottlaender, M, Hansson, O, Edison, P, Hinz, R, Boellaard, R, Moresco, R M, Pappata, S & IMBI Brain Imaging Working Group 2019, ' Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies ', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 11, pp. 327-332 . https://doi.org/10.1016/j.dadm.2019.02.004 Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 11, Iss 1, Pp 327-332 (2019) Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 11, 327-332. Elsevier BV
Edison, P, Hinz, R, Ramlackhansingh, A, Thomas, J, Gelosa, G, Archer, H A, Turkheimer, F E & Brooks, D J 2012, ' Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? ', NeuroImage, vol. 60, no. 3, pp. 1716-23 . https://doi.org/10.1016/j.neuroimage.2012.01.099